is semaglutide a hypoglycemic drug Frontiers Semaglutide - Wikipedia

Monitor Your Progress

What To Know OKAVA Pharmaceuticals dosed the first cat in its MEOW-1 study for OKV-119, a subdermal GLP-1 implant targeted at addressing obesity, diabetes, and kidney disease in cats

Mantovani A, Lombardi R, Cattazzo F, Zusi C, Cappelli D, Dalbeni A

2024/05/01 2024 doi: 10.1038/s41366-024-01527-1

Signs to look out for might be things like flimsy packaging, spelling mistakes or incorrect logos

Trying to put a good face on these clearly disappointing findings, Rohit Loomba presented them and said: Although the primary endpoint was not met, once-weekly semaglutide 2.4 mg appeared safe and was well-tolerated in this 48-week trial in patients with NASH and compensated cirrhosis. Last year a different phase 2 study with the same drug for the same disease yielded much more positive results